Wells Fargo’s Amgen AMGN Stock Holding History

Wells Fargo’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$739K	Hold	2,100	–	–	﹤0.01%	3923
2025 Q4	$687K	Buy	2,100 +900	+75%	+$285K	﹤0.01%	4237
2025 Q3	$339K	Sell	1,200 -119,000	-99%	-$34.5M	﹤0.01%	4594
2025 Q2	$33.6M	Buy	120,200 +117,700	+4,708%	+$33.3M	0.01%	1066
2025 Q1	$779K	Sell	2,500 -1,100	-31%	-$325K	﹤0.01%	3804
2024 Q4	$938K	Hold	3,600	–	–	﹤0.01%	3755
2024 Q3	$1.16M	Buy	3,600 +600	+20%	+$196K	﹤0.01%	3447
2024 Q2	$937K	Sell	3,000 -1,700	-36%	-$499K	﹤0.01%	3538
2024 Q1	$1.34M	Buy	4,700 +400	+9%	+$117K	﹤0.01%	3263
2023 Q4	$1.24M	Sell	4,300 -4,600	-52%	-$1.25M	﹤0.01%	3284
2023 Q3	$2.39M	Sell	8,900 -4,300	-33%	-$1.07M	﹤0.01%	2660
2023 Q2	$2.93M	Sell	13,200 -5,200	-28%	-$1.21M	﹤0.01%	2593
2023 Q1	$4.45M	Sell	18,400 -17,800	-49%	-$4.37M	﹤0.01%	2216
2022 Q4	$9.51M	Sell	36,200 -26,700	-42%	-$7.16M	﹤0.01%	1585
2022 Q3	$14.2M	Buy	62,900 +26,000	+70%	+$6.3M	﹤0.01%	1281
2022 Q2	$8.98M	Hold	36,900	–	–	﹤0.01%	1643
2022 Q1	$8.92M	Sell	36,900 -10,000	-21%	-$2.3M	﹤0.01%	1930
2021 Q4	$10.6M	Buy	+46,900	New	+$9.9M	﹤0.01%	1831
2021 Q3	–	Sell	-25,000	Closed	-$6.09M	–	6929
2021 Q2	$6.09M	Buy	+25,000	New	+$6.15M	﹤0.01%	2681
2020 Q4	–	Sell	-10	Closed	-$2K	–	6454
2020 Q3	$2K	Hold	10	–	–	﹤0.01%	6118
2020 Q2	$7K	Hold	10	–	–	﹤0.01%	5904
2020 Q1	$17K	Buy	+10	New	+$2.18K	﹤0.01%	5634
2019 Q4	–	Sell	-10	Closed	-$2K	–	6331
2019 Q3	$2K	Sell	10 -2,990	-100%	-$574K	﹤0.01%	6173
2019 Q2	$7K	Buy	+3,000	New	+$537K	﹤0.01%	5973
2017 Q4	–	Sell	-2,400	Closed	-$2K	–	6321
2017 Q3	$2K	Hold	2,400	–	–	﹤0.01%	6134
2017 Q2	$9K	Sell	2,400 -53,000	-96%	-$8.62M	﹤0.01%	5805
2017 Q1	$466K	Sell	55,400 -4,900	-8%	-$814K	﹤0.01%	4297
2016 Q4	$2K	Buy	60,300 +100	+0.2%	+$15.1K	﹤0.01%	6080
2016 Q3	$25K	Hold	60,200	–	–	﹤0.01%	5537
2016 Q2	$120K	Buy	60,200 +200	+0.3%	+$31.1K	﹤0.01%	4704
2016 Q1	$205K	Buy	60,000 +41,600	+226%	+$6.18M	﹤0.01%	4401
2015 Q4	$38K	Buy	18,400 +16,000	+667%	+$2.51M	﹤0.01%	5377
2015 Q3	$34K	Hold	2,400	–	–	﹤0.01%	5383
2015 Q2	$21K	Buy	+2,400	New	+$384K	﹤0.01%	5579
2014 Q4	–	Sell	-7,700	Closed	-$10K	–	6191
2014 Q3	$10K	Buy	7,700 +5,000	+185%	+$653K	﹤0.01%	5570
2014 Q2	$2K	Buy	+2,700	New	+$313K	﹤0.01%	5937
2014 Q1	–	Sell	-1,800	Closed	-$1K	–	5854
2013 Q4	$1K	Buy	+1,800	New	+$205K	﹤0.01%	5597

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wells Fargo's AMGN Position: Q1 2026 in Review

Wells Fargo reduced its Amgen (AMGN) stake by 0.32% in Q1 2026, selling an estimated $8.09M and leaving 7,088,010 shares worth $2.49B. The position accounts for 0.47% of the portfolio, ranked #34.

Wells Fargo first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Wells Fargo held 7,088,010 shares of Amgen worth $2.49B as of Q1 2026.
Wells Fargo sold 22,683 Amgen shares in Q1 2026, an estimated $8.09M.
Amgen made up 0.47% of Wells Fargo's portfolio in Q1 2026, its #34 holding.
Wells Fargo first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.